Patent Assignment
Reel/Frame 065529/0594
Security Interest
Recorded: 2023-11-10
Pages: 11
Assignors
AGEX THERAPEUTICS, INC.
Executed: 2023-11-09
RECYTE THERAPEUTICS, INC.
Executed: 2023-11-09
REVERSE BIOENGINEERING, INC.
Executed: 2023-11-09
Assignee
JUVENESCENCE LIMITED
18 ATHOL STREET, DOUGLAS, ISLE OF MAN, IM1 1JA, GREAT BRITAIN
Covered Properties
(31)
Inter-vial transfer system
Application:
14/544,019 →
Publication:
US 2015/0101708
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
16/211,690 →
Publication:
US 2019/0175691
Hla G-Modified Cells and Methods
Compositions and Methods for Detecting Cardiotoxicity
Application:
16/736,802 →
Publication:
US 2020/0225213
Mesenchymal Stem Cells with Enhanced Immunosuppressive Capability
Induced Tissue Regeneration Using Extracellular Vesicles
Application:
16/833,285 →
Publication:
US 2020/0306296
Improved Methods for Inducing Tissue Regeneration and Senolysis in Mammalian Cells
Application:
17/050,354 →
Publication:
US 2021/0180013
Compositions and Methods for Induced Tissue Regeneration in Mammalian Species
Differentially-Methylated Regions of the Genome Useful as Markers of Embryo-Adult Transitions
Application:
17/251,145 →
Publication:
US 2022/0316013
Perivascular Stromal Cells from Primate Pluripotent Stem Cells
Application:
17/361,611 →
Publication:
US 2022/0098554
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/542,992 →
Publication:
US 2022/0160833
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/542,997 →
Publication:
US 2022/0088137
Compositions and Methods for Induced Tissue Regeneration in Mammalian Species
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/543,020 →
Publication:
US 2022/0088138
Exosomes from Clonal Progenitor Cells
Application:
17/592,200 →
Publication:
US 2022/0403341
Methods for Generating Pluripotent Stem Cell-Derived Brown Fat Cells
Application:
17/825,112 →
Publication:
US 2023/0093399
Methods for the Ex Vivo Induction of Tissue Regeneration in Microbiopsies
Application:
18/272,044 →
Publication:
US 2024/0066070
Use of Protocadherins in Methods of Diagnosing and Treating Cancer
Application:
18/279,962 →
Publication:
US 2025/0188183
Methods and Compositions Used to Modify Chromatin Architecture to Regulate Phenotype in Aging and Cancer
Application:
18/279,963 →
Publication:
US 2024/0158788
Methods and Compositons for Producing Endothelial Progenitor Cells from Pluripotent Stem Cells
Application:
61/488,319 →
Methods and Compositons for Producing Endothelial Progenitor Cells from Pluripotent Stem Cells
Application:
61/496,436 →
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
62/347,075 →
Methods for the Ex Vivo Induction of Tissue Regeneration in Microbiopsies
Application:
63/136,515 →
Methods and Compositions Used to Modify Chromatin Architecture to Regulate Phenotype in Aging and Cancer
Application:
63/155,628 →
Use of Protocadherins in Methods of Diagnosing and Treating Cancer
Application:
63/155,631 →
Methods for the Temporal Regulation of Reprogramming Factors in Mammalian Cells
Application:
63/256,284 →
Methods for Modulating the Regenerative Phenotype in Mammalian Cells
Application:
63/256,286 →
Use of Protocadherins in Methods of Diagnosing and Treating Cancer
Application:
63/274,731 →
Methods and Compositions Used to Modify Chromatin Architecture to Regulate Phenotype in Aging and Cancer
Application:
63/274,734 →
Methods for the Temporal Regulation of Reprogramming Factors in Mammalian Cells
Application:
63/274,736 →
Improved Methods for Inducing the Maturation of Mammalian Cells
Application:
63/289,411 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 3, 2011
From: KESSLER, STEVEN
To: BIOTIME, INC.
Reel/Frame 026386/0290 →
Assignment of Assignor's Interest
Nov 9, 2011
From: KESSLER, STEVEN
To: BIOTIME, INC.
Reel/Frame 027202/0038 →
Assignment of Assignor's Interest
Sep 13, 2017
From: WEST, MICHAEL D.
To: BIOTIME, INC.
Reel/Frame 043579/0743 →
Assignment of Assignor's Interest
Aug 29, 2019
From: WEST, MICHAEL D.; LAROCCA, DAVID
To: BIOTIME, INC.
Reel/Frame 050215/0924 →
Assignment of Assignor's Interest
Mar 3, 2020
From: HANTASH, BASIL M.
To: ESCAPE THERAPEUTICS, INC.
Reel/Frame 051993/0153 →
Assignment of Assignor's Interest
Oct 7, 2020
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 054001/0950 →
Change of Name
Oct 7, 2020
From: BIOTIME, INC.
To: LINEAGE CELL THERAPEUTICS, INC.
Reel/Frame 054005/0749 →
Assignment of Assignor's Interest
Jun 4, 2021
From: WEST, MICHAEL D.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 056443/0076 →
Assignment of Assignor's Interest
Jun 4, 2021
From: WEST, MICHAEL D.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 056442/0428 →
Assignment of Assignor's Interest
Aug 2, 2021
From: YANG, JIWEI; LAROCCA, DANA; GREENWOOD-GOODWIN, MIDORI
To: RECYTE THERAPEUTICS, INC.
Reel/Frame 057052/0268 →
Assignment of Assignor's Interest
Oct 1, 2021
From: WEST, MICHAEL; CHAPMAN, KAREN; STERNBERG, HAL
To: BIOTIME, INC.
Reel/Frame 057668/0341 →
Assignment of Assignor's Interest
Oct 1, 2021
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 057668/0377 →
Assignment of Assignor's Interest
Oct 11, 2021
From: WEST, MICHAEL D.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 057751/0352 →
Change of Name
Dec 14, 2021
From: BIOTIME, INC.
To: LINEAGE CELL THERAPEUTICS, INC.
Reel/Frame 058380/0185 →
Assignment of Assignor's Interest
Jan 28, 2022
From: WEST, MICHAEL D.; STERNBERG, HAL
To: AGEX THERAPEUTICS, INC.
Reel/Frame 058816/0905 →
Assignment of Assignor's Interest
Jan 28, 2022
From: WEST, MICHAEL D.; STERNBERG, HAL
To: AGEX THERAPEUTICS, INC.
Reel/Frame 058816/0925 →
Change of Name
Mar 9, 2022
From: BIOTIME, INC.
To: LINEAGE CELL THERAPEUTICS, INC.
Reel/Frame 059357/0105 →
Assignment of Assignor's Interest
Mar 9, 2022
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 059211/0285 →
Merger and Change of Name
Mar 9, 2022
From: BIOTIME, INC.; LINEAGE CELL THERAPEUTICS, INC.
To: LINEAGE CELL THERAPEUTICS, INC.
Reel/Frame 059211/0304 →
Assignment of Assignor's Interest
Mar 9, 2022
From: WEST, MICHAEL D.; CHAPMAN, KAREN; STERNBERG, HAL
To: BIOTIME, INC.
Reel/Frame 059211/0320 →
Assignment of Assignor's Interest
Mar 9, 2022
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 059213/0084 →
Assignment of Assignor's Interest
Mar 9, 2022
From: WEST, MICHAEL D.; LAROCCA, DAVID
To: BIOTIME, INC.
Reel/Frame 059213/0272 →
Assignment of Assignor's Interest
Mar 10, 2022
From: AGEX THERAPEUTICS, INC.
To: REVERSE BIOENGINEERING, INC.
Reel/Frame 059226/0182 →
Assignment of Assignor's Interest
Mar 10, 2022
From: WEST, MICHAEL D.; STERNBERG, HAL
To: AGEX THERAPEUTICS, INC.
Reel/Frame 059226/0106 →
Assignment of Assignor's Interest
Mar 11, 2022
From: AGEX THERAPEUTICS, INC.
To: REVERSE BIOENGINEERING, INC.
Reel/Frame 059242/0007 →